Diagnostics of periodontitis based on salivary HGF and MMP-8
AssigneeKoninklijke Philips N.V.
InventorsBart Jacob Bakker, Marinus Karel Johannes De Jager, Amir Hussein Rmaile, Philip Preshaw, John Taylor
Life of this patent
Estimating the term…
Loading patent…
AssigneeKoninklijke Philips N.V.
InventorsBart Jacob Bakker, Marinus Karel Johannes De Jager, Amir Hussein Rmaile, Philip Preshaw, John Taylor
Estimating the term…
Disclosed is an in vitro method for assessing whether a human subject has periodontitis. The method comprises detecting, in a sample of saliva from said subject, the concentrations of the proteins Hepatocyte Growth Factor (HGF) and Matrix Metalloproteinase 8 (MMP-8). Based on the concentrations determined, and adding age, and possibly other demographic markers such as sex and/or BMI, a testing value reflecting the joint concentrations is determined for said proteins, in combination with one or more demographic markers. The testing value is compared with a threshold value. The threshold reflects in the same manner the joint concentrations and the age, and possibly other demographic markers, as associated with periodontitis and may be seen as an upper limit of testing values as seen in a population of subjects without periodontitis. Thereby a testing value at or above the threshold value is indicative for periodontitis in said subject.
A method for treating a human subject diagnosed with periodontitis, comprising:
An in vitro method for determining a change in status of oral health in a human subject over a time interval from a first time point t1 to a second time point t2, the method comprising:
A method for treating a subject diagnosed with periodontitis, comprising:
Dependencies are inferred from the claim text.